Gentiva Reaches $19.4 Million False Claims Act Settlement
Gentiva – formerly known as Kindred at Home – reached a $19.4 million settlement with the United States, resolving allegations…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Monthly Archives
October 2024
OPDP Sends Untitled Letter to Kaleo for Influencer Social Media Post
The United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) sent an Untitled Letter to…
DOJ Announces Corporate Whistleblower Award Pilot Program
The United States Department of Justice (DOJ) started a Corporate Whistleblower Awards Pilot Program to help uncover and prosecute…
Mirati Therapeutics Receives Untitled Letter from OPDP for Overstating…
The United States Food and Drug Administration (FDA) Office of Prescription Drug Promotion (OPDP) recently sent an untitled letter…
Pioneering Discussions at IISLD 2024: Advancing Treatment for PBC and…
This year's International Symposium on Liver Diseases (IISLD) 2024, held in the San Diego Convention Center, includes two key…
HHS Endorses Telehealth Accreditation Programs
In September of 2024, the U.S. Department of Health and Human Services (HHS) published its stamp of approval for telehealth…
Wholesale Drug Distributor Owners Indicted for Alleged Counterfeit HIV…
Owners of a wholesale drug distributor were recently indicted in the Southern District of Florida for alleged engagement in a…
Congressional Budget Office Releases: Alternative Approaches to Reducing…
As healthcare costs soar, the Congressional Budget Office (CBO) has recently shed light on a hot political issue: the perceived…
Global Update on Transparency Reporting: Key Changes and Compliance…
In a recent global compliance presentation at the Informaconnect Transparency, Aggregate Spend and HCP Engagement, Elan…
SCOTUS Rejects Chevron Deference
On June 28, 2024, the Supreme Court rejected the doctrine of Chevron deference in the closely watched case of Loper Bright…